Cited by

• D-Serine differently modulates NMDA receptor function in rat CA1 hippocampal pyramidal cells and interneurons.

  Martina M, Krasteniakov NV, Bergeron R. Martina M, et al. J Physiol. 2003 Apr 15;548(Pt 2):411-23. doi: 10.1113/jphysiol.2002.037127. Epub 2003 Feb 28. J Physiol. 2003. PMID: 12611916 Free PMC article.
• Phencyclidine (PCP)-like discriminative stimulus effects of metaphit and of 2-amino-5-phosphonovalerate in pigeons: generality across different training doses of PCP.

  Koek W, Woods JH, Jacobson AE, Rice KC. Koek W, et al. Psychopharmacology (Berl). 1987;93(4):437-42. doi: 10.1007/BF00207232. Psychopharmacology (Berl). 1987. PMID: 2893414
• Intraventricular infusion of N-methyl-D-aspartate. 1. Acute blood-brain barrier consequences.

  Dietrich WD, Alonso O, Halley M, Busto R, Globus MY. Dietrich WD, et al. Acta Neuropathol. 1992;84(6):621-9. doi: 10.1007/BF00227739. Acta Neuropathol. 1992. PMID: 1471471
• CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.

  Fagg GE, Olpe HR, Pozza MF, Baud J, Steinmann M, Schmutz M, Portet C, Baumann P, Thedinga K, Bittiger H, et al. Fagg GE, et al. Br J Pharmacol. 1990 Apr;99(4):791-7. doi: 10.1111/j.1476-5381.1990.tb13008.x. Br J Pharmacol. 1990. PMID: 1972895 Free PMC article.
• Developmental expression of N-methyl-D-aspartate (NMDA)-induced neurotoxicity, NMDA receptor function, and the NMDAR1 and glutamate-binding protein subunits in cerebellar granule cells in primary cultures.

  Xia Y, Ragan RE, Seah EE, Michaelis ML, Michaelis EK. Xia Y, et al. Neurochem Res. 1995 May;20(5):617-29. doi: 10.1007/BF01694545. Neurochem Res. 1995. PMID: 7643968